Biostar Pharmaceuticals, Inc.
BSPM · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $2 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $16 | $37 | $32 |
| Inventory | $0 | $0 | $1 | $1 |
| Other Curr. Assets | $0 | $0 | $4 | $3 |
| Total Curr. Assets | $7 | $16 | $44 | $36 |
| Property Plant & Equip (Net) | $6 | $7 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $7 | $13 | $17 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $3 | $5 | $7 | $3 |
| Other NC Assets | $21 | $16 | $9 | $4 |
| Total NC Assets | $35 | $35 | $38 | $32 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $43 | $51 | $81 | $68 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $5 | $4 |
| Short-Term Debt | $2 | $3 | $3 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | -$0 | -$0 | $0 |
| Total Curr. Liab. | $6 | $7 | $9 | $5 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6 | $7 | $9 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$3 | $3 | $28 | $24 |
| AOCI | $8 | $11 | $14 | $14 |
| Other Equity | $31 | $30 | $30 | $26 |
| Total Equity | $37 | $44 | $72 | $63 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $43 | $51 | $81 | $68 |
| Net Debt | $2 | $3 | $1 | -$0 |